Nifty
Sensex
:
:
17196.70
57696.46
-204.95 (-1.18%)
-764.83 (-1.31%)

Pharmaceuticals & Drugs - API

Rating :
42/99

BSE: 524348 | NSE: AARTIDRUGS

522.35
03-Dec-2021
  • Open
  • High
  • Low
  • Previous Close
  •  514.00
  •  526.00
  •  513.45
  •  512.55
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  174033
  •  905.38
  •  841.80
  •  484.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,830.02
  • 22.81
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 5,164.62
  • 0.48%
  • 5.17

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 60.12%
  • 0.58%
  • 32.68%
  • FII
  • DII
  • Others
  • 2.21%
  • 2.09%
  • 2.32%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.20
  • 12.51
  • 11.35

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.16
  • 18.25
  • 15.86

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 27.64
  • 27.94
  • 46.19

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.73
  • 17.29
  • 18.22

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.20
  • 4.13
  • 4.78

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.47
  • 11.38
  • 12.54

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Net Sales
579.62
578.11
0.26%
579.95
544.67
6.48%
501.75
449.64
11.59%
530.25
473.51
11.98%
Expenses
505.88
461.67
9.58%
500.26
410.70
21.81%
420.82
378.33
11.23%
424.49
406.02
4.55%
EBITDA
73.74
116.44
-36.67%
79.69
133.97
-40.52%
80.93
71.31
13.49%
105.76
67.49
56.70%
EBIDTM
12.72%
20.14%
13.74%
24.60%
16.13%
15.86%
19.95%
14.25%
Other Income
0.08
0.29
-72.41%
1.62
1.26
28.57%
0.97
0.98
-1.02%
2.00
0.25
700.00%
Interest
5.26
7.05
-25.39%
4.21
6.57
-35.92%
4.37
7.47
-41.50%
4.97
8.39
-40.76%
Depreciation
12.48
12.56
-0.64%
12.42
12.38
0.32%
12.28
12.49
-1.68%
12.65
12.36
2.35%
PBT
56.08
97.12
-42.26%
64.68
116.28
-44.38%
65.25
60.71
7.48%
90.36
43.08
109.75%
Tax
13.50
21.85
-38.22%
15.87
30.83
-48.52%
13.60
1.85
635.14%
22.33
15.30
45.95%
PAT
42.58
75.27
-43.43%
48.81
85.45
-42.88%
51.65
58.86
-12.25%
68.03
27.78
144.89%
PATM
7.35%
13.02%
8.42%
15.69%
10.29%
13.09%
12.83%
5.87%
EPS
4.60
2.02
127.72%
5.27
2.29
130.13%
5.54
6.32
-12.34%
7.30
2.98
144.97%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 11
Mar 10
Mar 09
Net Sales
2,191.57
2,154.78
1,806.09
1,560.94
1,243.63
1,195.17
1,139.84
1,096.88
501.05
478.50
382.12
Net Sales Growth
7.12%
19.31%
15.71%
25.51%
4.05%
4.85%
3.92%
118.92%
4.71%
25.22%
 
Cost Of Goods Sold
1,435.12
1,263.35
1,127.29
1,013.53
737.72
744.43
735.08
724.24
321.34
301.35
238.85
Gross Profit
756.45
891.43
678.79
547.40
505.91
450.75
404.77
372.65
179.71
177.15
143.27
GP Margin
34.52%
41.37%
37.58%
35.07%
40.68%
37.71%
35.51%
33.97%
35.87%
37.02%
37.49%
Total Expenditure
1,851.45
1,714.40
1,540.57
1,350.03
1,041.76
1,004.68
960.02
924.51
431.87
396.04
315.67
Power & Fuel Cost
-
98.20
103.83
84.39
71.42
59.42
53.93
49.56
29.07
26.48
23.27
% Of Sales
-
4.56%
5.75%
5.41%
5.74%
4.97%
4.73%
4.52%
5.80%
5.53%
6.09%
Employee Cost
-
65.88
61.35
54.55
52.14
47.95
40.19
33.26
19.93
14.77
12.00
% Of Sales
-
3.06%
3.40%
3.49%
4.19%
4.01%
3.53%
3.03%
3.98%
3.09%
3.14%
Manufacturing Exp.
-
181.41
160.38
142.69
130.01
103.21
87.60
75.53
39.18
32.32
25.17
% Of Sales
-
8.42%
8.88%
9.14%
10.45%
8.64%
7.69%
6.89%
7.82%
6.75%
6.59%
General & Admin Exp.
-
29.03
21.39
14.24
12.22
12.81
10.98
10.48
4.86
4.95
3.80
% Of Sales
-
1.35%
1.18%
0.91%
0.98%
1.07%
0.96%
0.96%
0.97%
1.03%
0.99%
Selling & Distn. Exp.
-
70.99
59.46
37.51
34.00
31.16
27.82
28.99
16.21
14.47
11.69
% Of Sales
-
3.29%
3.29%
2.40%
2.73%
2.61%
2.44%
2.64%
3.24%
3.02%
3.06%
Miscellaneous Exp.
-
5.54
6.88
3.11
4.24
5.71
4.42
2.45
1.27
1.71
11.69
% Of Sales
-
0.26%
0.38%
0.20%
0.34%
0.48%
0.39%
0.22%
0.25%
0.36%
0.23%
EBITDA
340.12
440.38
265.52
210.91
201.87
190.49
179.82
172.37
69.18
82.46
66.45
EBITDA Margin
15.52%
20.44%
14.70%
13.51%
16.23%
15.94%
15.78%
15.71%
13.81%
17.23%
17.39%
Other Income
4.67
4.53
1.48
2.41
1.05
4.00
0.00
0.65
0.16
0.63
0.52
Interest
18.81
26.23
37.42
43.51
38.36
40.02
48.02
42.28
17.12
18.66
26.45
Depreciation
49.83
49.88
48.75
42.56
40.06
38.46
36.53
31.02
19.11
17.03
14.48
PBT
276.37
368.79
180.82
127.26
124.50
116.01
95.27
99.72
33.11
47.40
26.04
Tax
65.30
88.62
43.89
41.27
42.20
34.21
26.55
22.47
9.61
18.96
8.47
Tax Rate
23.63%
24.02%
23.69%
31.50%
33.90%
29.49%
27.87%
22.53%
29.02%
40.00%
32.53%
PAT
211.07
280.41
141.40
89.75
82.31
81.80
68.72
77.25
23.50
28.06
16.71
PAT before Minority Interest
211.08
280.40
141.40
89.75
82.31
81.80
68.72
77.25
23.50
28.44
17.57
Minority Interest
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-0.38
-0.86
PAT Margin
9.63%
13.01%
7.83%
5.75%
6.62%
6.84%
6.03%
7.04%
4.69%
5.86%
4.37%
PAT Growth
-14.67%
98.31%
57.55%
9.04%
0.62%
19.03%
-11.04%
228.72%
-16.25%
67.92%
 
EPS
22.79
30.28
15.27
9.69
8.89
8.83
7.42
8.34
2.54
3.03
1.80

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 11
Mar 10
Mar 09
Shareholder's Funds
913.42
652.49
543.45
455.43
400.13
357.40
308.15
163.16
146.45
123.45
Share Capital
93.20
23.30
23.58
23.58
23.86
24.22
24.22
12.11
12.11
11.71
Total Reserves
820.22
629.19
519.86
431.85
376.27
333.18
283.94
151.05
134.34
111.53
Non-Current Liabilities
257.25
300.82
321.06
312.31
296.59
243.78
211.03
290.20
209.85
210.70
Secured Loans
138.99
171.74
199.64
190.53
187.38
176.66
152.72
204.83
138.66
160.86
Unsecured Loans
8.57
8.57
8.57
12.17
14.17
14.57
10.75
62.65
50.16
31.35
Long Term Provisions
21.67
25.13
12.32
16.87
8.39
1.42
0.29
0.00
0.00
0.00
Current Liabilities
595.36
623.19
590.98
621.68
494.31
501.02
482.76
70.10
57.99
59.62
Trade Payables
329.97
329.55
242.63
258.73
196.97
184.90
166.72
65.30
50.18
54.78
Other Current Liabilities
105.38
132.83
82.94
56.42
51.00
43.80
41.53
1.77
1.68
1.33
Short Term Borrowings
157.21
157.73
263.25
305.64
244.66
258.41
252.43
0.00
0.00
0.00
Short Term Provisions
2.80
3.08
2.16
0.89
1.68
13.91
22.08
3.03
6.13
3.51
Total Liabilities
1,766.01
1,576.50
1,455.49
1,389.42
1,191.03
1,102.20
1,001.94
523.46
419.15
403.24
Net Block
665.40
643.81
624.86
602.39
581.09
493.42
448.46
247.84
208.20
205.24
Gross Block
1,102.26
1,030.97
970.09
909.20
848.13
725.47
685.21
393.33
332.42
309.85
Accumulated Depreciation
436.86
387.16
345.22
306.81
267.04
232.05
236.75
145.49
124.21
104.61
Non Current Assets
709.22
672.50
671.20
652.55
619.61
536.97
476.40
263.50
213.35
207.43
Capital Work in Progress
19.26
12.21
32.75
28.45
14.28
34.04
16.06
10.37
3.40
0.64
Non Current Investment
17.30
13.36
12.44
10.76
11.94
4.63
4.63
5.28
1.74
1.55
Long Term Loans & Adv.
7.26
3.12
1.15
10.95
12.30
4.88
7.24
0.00
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
1,056.80
904.00
784.29
736.86
571.42
565.23
525.54
259.96
205.81
195.80
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
415.00
325.40
246.61
278.21
209.63
178.35
164.20
91.83
64.41
60.52
Sundry Debtors
555.23
488.63
458.54
374.94
296.81
331.69
314.27
121.34
115.87
113.48
Cash & Bank
9.78
7.64
5.55
4.27
4.17
4.82
3.58
5.27
8.52
3.48
Other Current Assets
76.79
6.82
6.56
10.21
60.81
50.37
43.49
41.52
17.01
18.32
Short Term Loans & Adv.
74.35
75.50
67.02
69.23
60.81
50.37
43.49
40.62
16.01
17.52
Net Current Assets
461.44
280.81
193.31
115.19
77.11
64.20
42.78
189.86
147.82
136.18
Total Assets
1,766.02
1,576.50
1,455.49
1,389.41
1,191.03
1,102.20
1,001.94
523.46
419.16
403.23

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 11
Mar 10
Mar 09
Cash From Operating Activity
154.85
250.74
143.09
69.77
174.75
133.29
104.59
20.56
59.12
64.90
PBT
369.01
185.29
131.02
124.50
116.01
95.27
99.72
33.11
47.40
26.04
Adjustment
68.60
86.84
75.20
75.12
71.63
79.30
69.40
38.76
38.77
41.71
Changes in Working Capital
-186.09
19.49
-33.49
-105.19
8.47
-21.25
-49.58
-40.22
-13.27
2.39
Cash after chg. in Working capital
251.53
291.62
172.74
94.44
196.11
153.33
119.53
31.65
72.90
70.14
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-96.68
-40.88
-29.64
-24.67
-21.36
-20.03
-14.94
-11.09
-13.80
-5.24
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-71.68
-33.21
-61.67
-73.54
-106.98
-98.79
-107.01
-76.36
-30.46
-11.51
Net Fixed Assets
-71.36
-45.34
-62.81
-72.64
-92.88
-46.34
-322.27
-65.29
-22.98
-19.64
Net Investments
-3.94
-1.46
-1.68
1.18
-7.30
-0.01
13.50
-3.23
0.00
12.15
Others
3.62
13.59
2.82
-2.08
-6.80
-52.44
201.76
-7.84
-7.48
-4.02
Cash from Financing Activity
-81.13
-215.41
-80.07
3.92
-68.23
-33.26
1.46
52.55
-23.62
-53.92
Net Cash Inflow / Outflow
2.04
2.13
1.35
0.15
-0.45
1.24
-0.95
-3.25
5.04
-0.53
Opening Cash & Equivalents
6.77
4.64
3.29
3.15
3.60
3.58
4.53
8.52
3.48
4.02
Closing Cash & Equivalent
8.81
6.77
4.64
3.29
3.15
4.82
3.58
5.27
8.52
3.49

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 11
Mar 10
Mar 09
Book Value (Rs.)
98.01
70.01
57.61
48.28
41.93
36.90
31.81
16.84
15.12
13.16
ROA
16.78%
9.33%
6.31%
6.38%
7.13%
6.53%
10.13%
4.99%
6.92%
4.29%
ROE
35.81%
23.65%
17.97%
19.24%
21.60%
20.65%
32.78%
15.18%
21.09%
14.97%
ROCE
34.52%
21.39%
17.01%
17.31%
18.50%
18.33%
23.93%
13.12%
20.30%
16.30%
Fixed Asset Turnover
2.02
1.81
1.66
1.44
1.64
1.75
2.19
1.45
1.57
1.42
Receivable days
88.41
95.71
97.45
97.10
89.05
95.59
67.25
82.06
83.04
95.17
Inventory Days
62.71
57.80
61.36
70.52
54.97
50.69
39.52
54.05
45.23
55.64
Payable days
68.71
64.68
68.08
73.82
67.66
65.68
45.51
45.97
46.92
62.87
Cash Conversion Cycle
82.41
88.83
90.73
93.79
76.36
80.60
61.26
90.14
81.35
87.94
Total Debt/Equity
0.38
0.58
0.93
1.20
1.20
1.26
1.45
1.64
1.29
1.56
Interest Cover
15.07
5.95
4.01
4.25
3.90
2.98
3.36
2.93
3.54
1.98

News Update:


  • Aarti Drugs - Quarterly Results
    27th Oct 2021, 15:50 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.